Dieterich DT, Brunet L, Hsu RK, Mounzer K, Pierone G, Wohlfeiler MB, Fusco JS, Dunbar MS, Gruber J, Yee LJ, Frenette C, Fusco GP. Tenofovir disoproxil fumarate and tenofovir alafenamide interruption in hepatitis B and human immunodeficiency virus co-infected individuals in the United States: monitoring practices and incidence of hepatitis B reactivation or hepatitis flare. European Association for the Study of the Liver Congress (EASL); June 5-8, 2024.
